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The role of chest computed tomography (CT) in COVID-19 remains to be defined. Chest CT was applied early and locally in the outbreak in China and, at the peak of the COVID-19 outbreak, was used alongside of reverse transcription polymerase chain 
reaction (RT-PCR) testing, to diagnose patients upon acute presentation to fever clinics in 
and around Wuhan in Hubei Province, China (1). It has recently become clear that one of the 
main challenges of COVID-19 containment is the prevalence of patients who are asymptom-
atic, but are infectious and transmitting the virus (2). The rapid transmission of SARS-CoV-2 
is partly because peak viral shedding occurs near the onset of symptoms, which means pa-
tients are unknowingly infectious well before clinical presentation (3). This is compounded 
by the fact that most patients with SARS-CoV-2, and therefore many people who transmit 
the virus have mild or no symptoms at all. A broad population testing program to limit the 
spread of the virus could consider the use of chest CT in addition to RT-PCR. Chest CT has 
been demonstrated to be even more sensitive than RT-PCR (4, 5), but has not been widely 
used for early COVID-19 detection in the United States and Europe. Limited availability of 
diagnostic methods for COVID-19 infection are a contributing factor to delayed diagnosis 
or incomplete information about prevalence. Delays in definitive diagnosis likely translate 
to incomplete isolation, due to reduced patient compliance with strict isolation slowing the 
mitigation process.
In some parts of China with high prevalence, COVID-19 was diagnosed despite RT-PCR 
negativity, with a positive CT plus high-risk travel or exposure history (6). Furthermore, in a 
study of 1040 patients, CT was shown to be more sensitive than PCR in their acute epidemic 
setting (4). Sensitivity of CT would go down in the absence of a severe epidemic with high 
prevalence, and likewise specificity of CT would go down in the presence of other viruses, 
such as influenza. However, the acceptance of positive exposure and CT-defined diagnosis 
may have captured a larger portion of the early COVID-19 population, than RT-PCR alone. In 
Hubei Province, such CT-positive patients were immediately isolated, which may have con-
tributed in part to successful containment and relatively less mortality than in other parts 
of the world. In US and Europe, CT has been used less frequently and typically only in the 
progression of the disease and its complications. Some US guidelines have recommended 
against using CT as a “screening” tool (7). These patterns of diagnosis should be carefully 
studied for associations between CT use, early detection rates, transmission rates, preva-
lence, and outcomes.
CT currently requires 30–60 minutes turnover time after the image acquisition for decon-
tamination and passive air exchange between patients (8). This results in many fewer pa-
tients per hour than in normal operations. The issue of passive air exchange time in between 
CT exams is critical for effective use of CT early in presentation or as a screening tool for PCR 
test negative individuals with persistent suspicion of COVID-19. The decontamination time 
can be potentially reduced or dismissed with use of custom enhanced containment devices. 
During the Chinese outbreak, in addition to an N-95 mask, a large air-tight protective plas-
tic bag was placed temporarily over the patient’s head with tape around the waist in order 
to reduce the aerosolization of SARS-CoV-2 from infectious patients (Figs. 1, 2) (9). Such an 
approach could reduce room turnover time significantly without having to wait for 30–60 
minutes of ventilation or ultraviolet sterilization. This could not only enable CT efficiency, 
but also could make utilization of targeted CT for COVID-19 screening more cost-effective.
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The additional relative cost of CT in this 
setting could go down by using a protec-
tive bag device, where 3–8 patients might 
theoretically be scanned per hour, instead 
of less than one with the current passive 
ventilation decontamination recommen-
dations. In an outbreak hotspot, the total 
healthcare cost of targeted early CT use is 
certainly less, by orders of magnitude, than 
not using CT. Although the exact impact of 
testing with both CT and RT-PCR is specu-
lative, early diagnosis across an outbreak 
is fundamental to containment. Ignoring 
early use of CT could send undiagnosed 
COVID-19 pneumonia patients home or 
out into the community to further spread 
the virus. Not all of these patients may be 
symptomatic enough to self-quarantine 
strictly. Although PCR sensitivity has likely 
improved since the referenced study, let’s 
assume a 98% sensitivity for CT and 71% 
sensitivity for PCR in an acute setting (4). 
In this case, 27% more patients with early 
COVID-19 pneumonia would potential-
ly be diagnosed with CT. Thus, CT would 
miss 2/100 patients while PCR would miss 
29/100 patients. Therefore, 27 of 100 pa-
tients would be misled by a false-negative 
PCR during the serial interval, which is when 
contact tracing occurs. Assuming a 35% 
noncompliance rate for strict isolation be-
haviors (10), 9 of 27 patients would further 
spread the virus unknowingly. Assuming a 
reproduction number of 2.2 (transmission 
rate per person), approximately 20 addi-
tional infections would quickly expand in 
number. These 20 newly infected patients 
will go on to infect 44 others after another 4 
days, and so on. Finally, these undiagnosed 
COVID-19 pneumonia cases could benefit 
from earlier care and monitoring, especially 
if and when an early therapy proves helpful. 
In this example, the additional cost of 
targeted CT for tracing would be far out-
weighed by the cost of not isolating new 
infections and the subsequent generations 
of infections. Any tool that can diagnose 
asymptomatic people who are shedding 
SARS-CoV-2 viral particles should be strong-
ly considered, given the downstream global 
economic impact of ineffective mitigation 
methods. CT does not have to be broadly 
applied to a population to be an effective 
tool. There are approximately 15  000 CT 
scanners in the USA and nearly 100 million 
CT scans are performed per year. Utilization 
is low at present. Targeted CT may augment 
current tracing and prevalence gathering 
efforts. Any use of CT comes with added 
risks of exposures by bringing infected peo-
ple together with non-infected people, so 
strict isolation is key, with dedicated access 
routes defined. Chest x-ray remains more 
widely available, and the role of imaging 
may depend upon local practices, resourc-
es, and access (11). 
With the current disinfection recom-
mendations, CT with a mandatory 1-hour 
disinfection interval in between patients 
might not be fiscally viable nor efficient. 
However, with custom bags and aggressive 
CT use with expedited throughput, chest 
CT in the pre-symptomatic and early onset 
COVID-19 patients might ultimately prove 
both ethical and cost-effective. Over 85% of 
COVID-19 infections went undocumented 
early on in China prior to implementation 
of aggressive CT and PCR testing (12). More 
use of CT early in the disease might de-
compress testing bottlenecks due to staff-
ing or supplies. "Stay at home" orders may 
also make CT more accessible. Additionally, 
characterization of viral shedding dynamics 
and identification of asymptomatic patients 
through CT scans could provide increased 
prevalence data for modeling pandemic 
mitigation, reopening or exit strategies. 
Clinical trials with CT correlates may arrive 
at useful drugs sooner, and early diagnosis 
with CT may lead to better outcomes for 
any anti-viral drugs that might shorten the 
disease course when given early (like in-
fluenza antivirals). CT may also classify the 
ventilated critical patient into two distinct 
phenotypes of physiology and outcomes, 
which merits further examination (13). One 
recent experience in high prevalence north-
ern Italy reported the benefits of CT over 
chest x-ray, in terms of more confidently rul-
ing out and ruling in COVID-19 (14). No con-
sensus exists on the integrated use of chest 
x-ray or CT for assessment, triage or man-
agement of symptomatic or asymptomatic 
patients suspected to have COVID-19 pneu-
monia, although practices vary widely by 
location and resources (11, 15). 
In light of these insights, professional so-
cieties, advocacy groups, epidemiologists, 
and public health experts might consider 
CT as part of an early diagnostic array of 
testing tools when formulating or revising 
recommendations. The exact role of CT re-
mains unclearly defined and may depend 
upon prevalence. Further research may 
prove targeted CT to be a cost-effective 
epidemiological tool that could play an im-
portant role in more effective containment 
or mitigation of COVID-19 outbreaks or tri-
age of the critical patient. 
Figure 1. CT contamination reduction equipment placed outside the N-95 mask to reduce the room 
turnover time. Reproduced with permission from reference 9.
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with elastic waistband being donned by 2 staff (a), and oxygen intake nipple for oxygen and integrated 
exit filter (N-95/FFP2 grade). The flat “hat” top maintains the bag material away from the face while 
upright (a) or supine (b). The patient wears an N-95 or FFP2 to further reduce air and surface exposures 
in CT, and to minimize the risk of airway obstruction from bag. Photo courtesy Civco Medical Solutions 
Inc., Coralville, Iowa, USA and NIH Center for Interventional Oncology, Bethesda, MD.
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